Bischofberger Norbert W 的 Form 4 申報
Kronos Bio, Inc.（KRON），2022/5/19 申報
- 申報編號
- 0001209191-22-030688
- 申報時間
- 2022/5/19
- 交易日
- 2022/5/17-5/19
- 申報延遲
- 2 天
- 10b5-1 計畫
- 表單沒有這欄（2023 年以前）
這份申報列了 3 筆非衍生性交易。公開市場買進合計 $224.9 萬。交易後 2 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Bischofberger Norbert WCIK 0001190273 | 董事、高階主管（總裁、執行長） |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F1
The weighted average purchase price for the transaction reported was $3.8329, and the range of prices were between $3.70 and $3.95. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.
表 I 有 1 筆交易的價格引用這則附註。
- F2
The weighted average purchase price for the transaction reported was $3.7248, and the range of prices were between $3.60 and $4.00. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.
表 I 有 1 筆交易的價格引用這則附註。
- F3
The weighted average purchase price for the transaction reported was $3.7817, and the range of prices were between $3.54 and $4.00. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.
表 I 有 1 筆交易的價格引用這則附註。